KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash from Financing Activities (2020 - 2025)

Oscar Health (OSCR) has disclosed Cash from Financing Activities for 6 consecutive years, with $364.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities rose 1861.39% year-over-year to $364.0 million, compared with a TTM value of $394.9 million through Sep 2025, up 501.55%, and an annual FY2024 reading of $68.4 million, up 960.94% over the prior year.
  • Cash from Financing Activities was $364.0 million for Q3 2025 at Oscar Health, up from $22.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.2 billion in Q1 2021 and bottomed at $423000.0 in Q3 2022.
  • Average Cash from Financing Activities over 5 years is $105.6 million, with a median of $4.9 million recorded in 2025.
  • The sharpest move saw Cash from Financing Activities skyrocketed 274006.33% in 2021, then plummeted 99.83% in 2023.
  • Year by year, Cash from Financing Activities stood at $13.0 million in 2021, then crashed by 95.94% to $527000.0 in 2022, then skyrocketed by 102.85% to $1.1 million in 2023, then skyrocketed by 257.06% to $3.8 million in 2024, then soared by 9437.18% to $364.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for OSCR at $364.0 million in Q3 2025, $22.1 million in Q2 2025, and $4.9 million in Q1 2025.